When does ALAUNOS THERAPEUTICS INC (TCRT) report earnings?
ALAUNOS THERAPEUTICS INC (TCRT) will report earnings on 2026-03-30, after the market close.
ALAUNOS THERAPEUTICS INC (TCRT) Forecast, Price Target & Analyst Ratings
NASDAQ:TCRT • US98973P3091
Current stock price
3.14 USD
-0.06 (-1.88%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALAUNOS THERAPEUTICS INC (TCRT).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $3.14 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
TCRT was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about TCRT.
In the previous month the buy percentage consensus was at a similar level.
TCRT was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-08-16 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-08-15 | Laidlaw & Co. | Downgrade | Buy -> Hold |
| 2023-05-15 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2022-05-04 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 30, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.922M 634.17% | 5K -99.83% | 10K 100.00% | 568.06M 5,680,500.00% | -100.00% | |||||
| EBITDA YoY % growth | -32.479M 53.97% | -26.178M 19.40% | -4.81M 81.63% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -35.238M 51.83% | -28.493M 19.14% | -4.812M 83.11% | 138.77M 2,983.83% | -40.419M -129.13% | -35.895M 11.19% | -27.303M 23.94% | -26.423M 3.22% | -27.495M -4.06% | |
| Operating Margin | -1,205.95% | -569,860.00% | -48,120.00% | 24.43% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -27.00 51.35% | -22.90 15.19% | N/A 97.33% | 0.88 243.33% | -0.14 -116.28% | -0.12 14.29% | -0.09 25.00% | -0.09 | -0.09 |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.64%
EPS Next 5 Year
13.09%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ALAUNOS THERAPEUTICS INC / TCRT Forecast FAQ
Can you provide the consensus rating for ALAUNOS THERAPEUTICS INC stock?
The consensus rating for ALAUNOS THERAPEUTICS INC (TCRT) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.